Cardiovascular
-
BA8989 ZeteletinibSummary: Zeteletinib (BOS-172738; DS-5010) is an orally effective, selective kinase inhibitor with nanomolar potency against and >300-fold selectivity for VEGFR2. - BA8843 CTA056Summary: CTA056 is an (IL-2 inducible T cell kinase) inhibitor.
- BA7581 DiacetoxyscirpenolSummary: Diacetoxyscirpenol (DAS) is a mono-terminal mycotoxin that is a secondary metabolite of fungi.
- BA7032 MoringinSummary: Moringin is a potent and selective natural agonist of ion channels.
- BA6541 AD57Summary: A multikinase inhibitor with oral activity.
- BA6455 HirsutenoneSummary: Hirsutenone, an active diheptanone contained in alder, has a variety of biological activities including anti-inflammatory, anti-tumor and anti-atopic dermatitis.
- BA6157 IvonescimabSummary: Ivonescimab (AK112) is a /bispecific antibody.
- BA4410 Takeda-6DSummary: Takeda-6D is an orally effective inhibitor at 7.0 and 2.2 nM, respectively.
- BA3744 OrobolSummary: Orobol is a major soy isoflavone with a variety of pharmacological activities, including anti-skin aging and anti-obesity effects.
- BA2886 MBM-55Summary: MBM-55 is an effective inhibitor.